Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;26(5):1843-1853.
doi: 10.1111/hex.13778. Epub 2023 Jun 13.

Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study)

Affiliations

Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study)

Aurélie Bocquier et al. Health Expect. 2023 Oct.

Abstract

Introduction: Despite various efforts to improve human papillomavirus (HPV) vaccine coverage in France, it has always been lower than in most other high-income countries. The health authorities launched in 2018 the national PrevHPV research programme to (1) co-develop with stakeholders and (2) evaluate the impact of a multicomponent complex intervention aimed at improving HPV vaccine coverage amongst French adolescents.

Objective: To describe the development process of the PrevHPV intervention using the GUIDance for rEporting of intervention Development framework as a guide.

Methods: To develop the intervention, we used findings from (1) published evidence on effective strategies to improve vaccination uptake and on theoretical frameworks of health behaviour change; (2) primary data on target populations' knowledge, beliefs, attitudes, preferences, behaviours and practices as well as the facilitators and barriers to HPV vaccination collected as part of the PrevHPV Programme and (3) the advice of working groups involving stakeholders in a participatory approach. We paid attention to developing an intervention that would maximise reach, adoption, implementation and maintenance in real-world contexts.

Results: We co-developed three components: (1) adolescents' and parents' education and motivation using eHealth tools (web conferences, videos, and a serious video game) and participatory learning at school; (2) general practitioners' e-learning training on HPV using motivational interviewing techniques and provision of a decision aid tool and (3) easier access to vaccination through vaccination days organised on participating middle schools' premises to propose free of charge initiation of the HPV vaccination.

Conclusion: We co-developed a multicomponent intervention that addresses a range of barriers and enablers of HPV vaccination. The next step is to build on the results of its evaluation to refine it before scaling it up if proven efficient. If so, it will add to the small number of multicomponent interventions aimed at improving HPV vaccination worldwide.

Patient or public contribution: The public (adolescents, their parents, school staff and health professionals) participated in the needs assessment using a mixed methods approach. The public was also involved in the components' development process to generate ideas about potential activities/tools, critically revise the successive versions of the tools and provide advice about the intervention practicalities, feasibility and maintenance.

Keywords: co-construction; complex Intervention; eHealth tools; human papillomavirus; motivational interview; vaccination behaviours.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
General logic model of the PrevHPV intervention. GP, general practitioner; HPV, human papillomavirus.

References

    1. WHO . Human papillomavirus (HPV) and cervical cancer. February 22, 2022. Accessed November 8, 2022. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(h...
    1. WHO . Human papillomavirus vaccines: WHO position paper, May 2017. Weekly Epidemiol Rec. 2017;19:241‐268. - PubMed
    1. WHO . Human Papillomavirus (HPV). WHO. https://www.who.int/teams/health-product-policy-and-standards/standards-...
    1. IARC, WHO . The Global Cancer Observatory—World. Source: Globocan 2020. March 2021. Accessed November 8, 2022. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-she...
    1. IARC, WHO . The Global Cancer Observatory—France. Source: Globocan 2020. March 2021. Accessed November 8, 2022. https://gco.iarc.fr/today/data/factsheets/populations/250-france-fact-sh...

Publication types

Substances

LinkOut - more resources